Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Nicklin

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 7, 2007
Development of renal-targeted vectors through combined in vivo phage display and capsid engineering of adenoviral fibers from serotype 19pLaura Denby, Lorraine M Work, Dan J Von Seggern, et al.
Journal of Virology|June 8, 2007
Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5Simon N Waddington, Alan L Parker, Menzo Havenga, et al.
Circulation|January 21, 2004
Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectorsStephen J White, Stuart A Nicklin, Hildegard Büning, et al.
The Journal of Biological Chemistry|February 1, 2022
Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensorNina Divorty, Laura Jenkins, Amlan Ganguly, et al.
Cancer Letters|November 11, 2003
Transductional and transcriptional targeting of cancer cells using genetically engineered viral vectorsStuart A Nicklin, Kate L Dishart, Hildegard Buening, et al.
Plos Pathogens|October 16, 2010
Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor XAngela C Bradshaw, Alan L Parker, Margaret R Duffy, et al.
Journal of Virology|April 7, 2017
Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction <i>In Vitro</i> in the Presence of Mouse SerumEstrella Lopez-Gordo, Andor Doszpoly, Margaret R Duffy, et al.
Journal of Hypertension|December 7, 2013
Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ10, and angiotensin receptor blocker, losartan, on cardiovascular functionJennifer McLachlan, Elisabeth Beattie, Michael P Murphy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2004
Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in ratsCampbell G Nicol, Delyth Graham, William H Miller, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
Development of efficient viral vectors selective for vascular smooth muscle cellsLorraine M Work, Stuart A Nicklin, Nick J R Brain, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 7, 2007
Development of renal-targeted vectors through combined in vivo phage display and capsid engineering of adenoviral fibers from serotype 19pLaura Denby, Lorraine M Work, Dan J Von Seggern, et al.
Journal of Virology|June 8, 2007
Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5Simon N Waddington, Alan L Parker, Menzo Havenga, et al.
Circulation|January 21, 2004
Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectorsStephen J White, Stuart A Nicklin, Hildegard Büning, et al.
The Journal of Biological Chemistry|February 1, 2022
Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensorNina Divorty, Laura Jenkins, Amlan Ganguly, et al.
Cancer Letters|November 11, 2003
Transductional and transcriptional targeting of cancer cells using genetically engineered viral vectorsStuart A Nicklin, Kate L Dishart, Hildegard Buening, et al.
Plos Pathogens|October 16, 2010
Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor XAngela C Bradshaw, Alan L Parker, Margaret R Duffy, et al.
Journal of Virology|April 7, 2017
Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction <i>In Vitro</i> in the Presence of Mouse SerumEstrella Lopez-Gordo, Andor Doszpoly, Margaret R Duffy, et al.
Journal of Hypertension|December 7, 2013
Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ10, and angiotensin receptor blocker, losartan, on cardiovascular functionJennifer McLachlan, Elisabeth Beattie, Michael P Murphy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2004
Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in ratsCampbell G Nicol, Delyth Graham, William H Miller, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
Development of efficient viral vectors selective for vascular smooth muscle cellsLorraine M Work, Stuart A Nicklin, Nick J R Brain, et al.
Pageof 8